Study identifies HOXA10 gene as key to preserving bone stem cell supply
Researchers at NYU Langone Health have determined that the HOXA10 gene prevents premature maturation of bone stem cells, ensuring long-term regenerative capacity.
A study published in Science Advances reports that the HOXA10 gene is essential for maintaining the pool of stem cells responsible for bone healing throughout a lifespan. The research indicates that these cells rely on the gene to balance self-renewal with the maturation process. In experiments where the gene was deleted in mice, 90 percent of the stem cell population was lost within 15 months as the cells prematurely turned into bone-building osteoblasts.
Dr. Philipp Leucht, corresponding author of the study, noted that HOXA10 acts as a brake on cell maturation. Beyond preserving cell numbers, the gene ensures that collagen proteins at fracture sites are properly aligned, which is necessary for new bone to harden. In human cell biopsies, the silencing of related HOX genes led to even more pronounced cell death, suggesting a critical dependence on these genes for human skeletal health.
These findings offer insight into why bone healing capabilities often decline with age as stem cell reserves become depleted. By defining the role of HOXA10, researchers have identified a potential target for therapeutic interventions designed to enhance skeletal regeneration in clinical settings.